Patents by Inventor Nicholas Catsimpoolas

Nicholas Catsimpoolas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5066496
    Abstract: Ganglioside mixtures and/or lipid mixtures e.g. from brain and omentum, are found to be effective to treat peptic ulcers.
    Type: Grant
    Filed: August 3, 1988
    Date of Patent: November 19, 1991
    Assignees: Angio-Medical Corporation, Trustees of Boston University
    Inventors: Sandor Szabo, Meryl S. A. Rubin, Michael Klibaner, Ahmad R. Kamarei, Robert S. Sinn, Nicholas Catsimpoolas
  • Patent number: 4990333
    Abstract: Factors isolated from omental extracts are used to promote bone healing, for example in fractures in mammals.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: February 5, 1991
    Assignees: Angio Medical Corporation, Trustees of Boston University
    Inventors: Joseph Lane, Nicholas Catsimpoolas, Robert S. Sinn
  • Patent number: 4957741
    Abstract: Lipid material or ganglioside from mammalian sources e.g. bovine and porcine brain or omentum is used to treat peptic ulcers.
    Type: Grant
    Filed: August 2, 1988
    Date of Patent: September 18, 1990
    Assignee: Angio-Medical Corp.
    Inventors: Ahmad R. Kamarei, Nicholas Catsimpoolas, Robert McCluer, Takashi Mise, Robert S. Sinn
  • Patent number: 4921838
    Abstract: A method for enhancing angiogenesis and/or blood vascular perfusion in mammals by administering a pharmacologically effective amount of specific angiogenically active non-ionic, anionic, cationic and zwitterionic amphiphilic compounds. An angiogenically effective amount of the angiogenically active compound digitonin is in the range of at least 1.25 microgram to at least 200 microgram of digitonin. The range including enhancement of vascular perfusion is up to 50 mg of digitonin.
    Type: Grant
    Filed: June 16, 1987
    Date of Patent: May 1, 1990
    Assignees: Trustees of Boston University, Angio-Medical Corp.
    Inventors: Nicholas Catsimpoolas, Ann L. Griffith, Robert S. Sinn
  • Patent number: 4895838
    Abstract: A method for causing or increasing angiogenesis is described. The method involves administering to a subject, such as a human being in need of angiogenesis an angiogenically effective amount of an angiogenically effective, pharmaceutically acceptable oligosaccharide or mixture of oligosaccharides.
    Type: Grant
    Filed: March 9, 1988
    Date of Patent: January 23, 1990
    Assignees: Trustees of Boston University, Angio-Medical Corporation
    Inventors: Robert McCluer, Nicholas Catsimpoolas, Michael Klibaner, Ann Griffith, Robert Sinn
  • Patent number: 4888324
    Abstract: Compositions which contain lipid containing molecules possessing angiogenic activity are disclosed. The lipid containing molecules have been found in mammalian tissue, particularly the omentum, of various animals. Additionally, known lipids, such as gangliosides, are unexpectedly found to possess angiogenic activity. A method for obtaining the omentum-derived lipids, and for use of these and known lipids, are disclosed as well.
    Type: Grant
    Filed: November 2, 1987
    Date of Patent: December 19, 1989
    Assignees: Angio-Medical Corporation, Trustees of Boston University
    Inventors: Nicholas Catsimpoolas, Robert McCluer, Robert S. Sinn, James Evans
  • Patent number: 4879114
    Abstract: 36 Lipid extracts and lipid fractions from mammalian omenta containing mostly lipids are used cosmetically for skin conditions, skin care and cosmetic products which products have skin softening applications without skin irritation, greasiness or mutagenic effect. These materials with and without ganglioside are used for skin conditions such as keratosis, white spots and the like.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: November 7, 1989
    Assignee: Angio-Medical Corporation
    Inventors: Nicholas Catsimpoolas, Ahmad R. Kamarei, Ann L. Griffith, Robert S. Sinn
  • Patent number: 4778787
    Abstract: Angiogenesis healing factors residing in omentum-derived lipid fractions with or without gangliosides or their synthetic equivalents can be used to treat myocardial ischemic conditions including but not limited to myocardial infarction, angina, as well as in heart transplant, vascular grafts, and re-opened vessels leading to improved vascularization, perfusion, collagenization and organization of said lesions; the involved and adjacent tissues.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: October 18, 1988
    Assignees: Trustees of Boston University, Angio-Medical Corporation
    Inventors: Nicholas Catsimpoolas, Haralambos Gavras, Christian C. Haudenschild, Michael I. Klibaner
  • Patent number: 4769362
    Abstract: Lipid containing molecules and compositions, including gangliosides and omental tissue extracts had previously been found to be effective in increasing angiogenesis. It has now been found that these same materials cause increased localized perfusion in mammals. A method for providing increased perfusion, using these compositions, is presented herein.
    Type: Grant
    Filed: April 14, 1986
    Date of Patent: September 6, 1988
    Assignees: Trustees of Boston University, Angio-Medical Corporation
    Inventors: Nicholas Catsimpoolas, Robert McCluer, James Evans, Robert S. Sinn
  • Patent number: 4767746
    Abstract: Omental lipid fractions accelerate wound healing especially as to epithelialization in mammals.
    Type: Grant
    Filed: December 4, 1985
    Date of Patent: August 30, 1988
    Assignees: Trustees of Boston University, Angio-Medical Corporation
    Inventors: Nicholas Catsimpoolas, Robert S. Sinn
  • Patent number: 4766111
    Abstract: Plasmin inhibitory substances have been found in mammalian omental extracts. The substances all contain lipid components. In addition, related commercially available lipid containing molecules, such as mono-, di-, and trisialogangliosides are found to possess unexpected plasmin inhibitory properties. This suggests methods of therapy for diseases and conditions where blood clotting and fibrin degradation products, are implicated.
    Type: Grant
    Filed: March 23, 1987
    Date of Patent: August 23, 1988
    Assignee: Trustees of Boston University
    Inventor: Nicholas Catsimpoolas
  • Patent number: 4710490
    Abstract: Compositions which contain lipid containing molecules possessing angiogenic activity are disclosed. The lipid containing molecules have been found in mammalian tissue, particularly the omentum, of various animals. Additionally, known lipids, such as gangliosides, are unexpectedly found to possess angiogenic activity. A method for obtaining the omentum-derived lipids, and for use of these and known lipids, are disclosed as well.
    Type: Grant
    Filed: October 1, 1985
    Date of Patent: December 1, 1987
    Assignees: Angio Medical Corporation, Trustees of Boston University
    Inventors: Nicholas Catsimpoolas, Robert McCluer, Robert S. Sinn, James Evans
  • Patent number: 4699788
    Abstract: A novel angiogenic composition obtained from the omentum is provided which acts as a potent and effective factor for blood perfusion enhancement and for the development of new blood vessels in an organized structural network in living tissues. The angiogenic composition is a lipid or lipids, essentially protein-free as extracted from the omentum using organic solvents. This composition can then be injected to target to a site where new blood vessel formation, or blood perfusion enhancement is required. This material can be used to heal various damaged tissues including bone and heart.
    Type: Grant
    Filed: August 20, 1984
    Date of Patent: October 13, 1987
    Assignee: Trustees of Boston University
    Inventors: Nicholas Catsimpoolas, Harry S. Goldsmith
  • Patent number: 4673667
    Abstract: Plasmin inhibitory substances have been found in mammalian omental extracts. The substances all contain lipid components. In addition, related commercially available lipid containing molecules, such as mono-, di-, and trisialogangliosides are found to fossess unexpected plasmin inhibitory properties. This suggests methods of therapy for diseases and conditions where blood clotting and fibrin degradation products, are implicated.
    Type: Grant
    Filed: October 31, 1985
    Date of Patent: June 16, 1987
    Assignee: Trustees of Boston University
    Inventor: Nicholas Catsimpoolas
  • Patent number: 4500524
    Abstract: Seizures are inhibited or prevented and tranquilizing effect induced by administering riboflavin or a riboflavin analog, alone or in combination with a conventional anticonvulsant or tranquilizer to enhance its effect.
    Type: Grant
    Filed: August 11, 1983
    Date of Patent: February 19, 1985
    Assignee: Trustees of Boston University
    Inventor: Nicholas Catsimpoolas
  • Patent number: 4448150
    Abstract: An animal activity housing and monitor includes several vertically displaced levels of animal cages 32 which are angularly disposed about a core 28. The core is mounted for rotation relative to the animal cages and for fiberoptic communication with the cages. The fiberoptic filaments provide for at least one light beam to be sequentially transmitted across the cages within each level for detecting animal position. Surrounding the central core are animal activity stations 36 which may be used for animal weighing, feeding, or experimentation. The cage support structure 24 is mounted for rotational positioning so that cages may be positioned at animal activity stations 36.
    Type: Grant
    Filed: September 15, 1982
    Date of Patent: May 15, 1984
    Assignee: Trustees of Boston University
    Inventor: Nicholas Catsimpoolas
  • Patent number: 4375401
    Abstract: An improved electrophoresis system for simple, rapid and reproducible separations of biological materials such as proteins, nucleic acids, cells, bacteria, cell organelles, etc. is described. The system consists of several subsystems including a first dimensional system having a multi-column rotatable carousel with automatic density gradient maker and sample deposition, a unique fraction collector cassette which can serve as a sample applicator for the second dimension electrophoresis and a slab-gel second-dimensional electrophoresis system. The total system operation is integrated by microprocessor control. Flexibility in the system design and operation allows for running in an analytical or preparative mode at the discretion of the system operator.
    Type: Grant
    Filed: May 20, 1981
    Date of Patent: March 1, 1983
    Inventor: Nicholas Catsimpoolas